Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Thomas J Hwang, M.D.

Concepts (215)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Drug Approval3320248216.510 Why?
United States Food and Drug Administration32202416733.020 Why?
Device Approval920231642.900 Why?
Drug Costs13202311952.790 Why?
Prescription Drugs720236352.320 Why?
Legislation, Drug620232162.210 Why?
Medicare Part D520223552.190 Why?
European Union920241582.090 Why?
Rare Diseases520196311.810 Why?
Drug Information Services32020511.770 Why?
Clinical Trials as Topic15202480521.670 Why?
Drugs, Investigational520192111.600 Why?
Product Surveillance, Postmarketing520234651.540 Why?
Drug Discovery7201710681.360 Why?
Drug and Narcotic Control220221451.270 Why?
Antineoplastic Agents152024136771.260 Why?
Neoplasms182024223711.240 Why?
Government Regulation320195251.170 Why?
Medicare Part B220191161.080 Why?
Orphan Drug Production42018480.980 Why?
Pediatrics6202036290.940 Why?
Consumer Product Safety220161220.930 Why?
Policy Making420165460.920 Why?
United States542024730390.890 Why?
Biomedical Research6201934630.860 Why?
Health Care Reform2202212560.850 Why?
BCG Vaccine220233810.820 Why?
Medicaid4202328400.820 Why?
Drugs, Essential12022710.780 Why?
Pharmaceutical Preparations9202310880.730 Why?
Drug Industry820237910.730 Why?
Federal Government120222660.710 Why?
Europe11202334360.690 Why?
Health Policy7202026970.680 Why?
Prescription Fees220211530.660 Why?
Inflation, Economic12019300.650 Why?
Cost Sharing220224090.650 Why?
Drug Evaluation120206420.640 Why?
Technology Assessment, Biomedical120223120.640 Why?
Commerce220156120.640 Why?
Health Expenditures3202223890.620 Why?
Cultural Diversity120223730.620 Why?
Urologic Neoplasms120223140.610 Why?
Clinical Trials, Phase III as Topic320188780.600 Why?
Artificial Intelligence2202426660.570 Why?
Tuberculosis, Multidrug-Resistant320149440.560 Why?
Medical Device Recalls12016150.540 Why?
Anti-Bacterial Agents4201674770.530 Why?
World Health Organization1202213280.530 Why?
Medicine120249450.520 Why?
Costs and Cost Analysis4202316670.500 Why?
State Health Plans120172200.500 Why?
Decision Support Systems, Clinical1202411780.490 Why?
Health Planning Technical Assistance1201450.480 Why?
Surgical Equipment12015570.480 Why?
Public-Private Sector Partnerships120161230.480 Why?
Insurance, Pharmaceutical Services120173480.470 Why?
Small Business1201490.470 Why?
Program Development2202013000.470 Why?
Visual Prosthesis12015480.460 Why?
Leprostatic Agents12014130.460 Why?
Humans8120247681710.450 Why?
Clofazimine12014410.450 Why?
Equipment and Supplies120162740.440 Why?
Urinary Bladder Neoplasms2202321950.430 Why?
Extensively Drug-Resistant Tuberculosis12014860.430 Why?
Information Seeking Behavior120141160.420 Why?
Research Design3201962090.420 Why?
Publishing220188370.420 Why?
Reimbursement Mechanisms220166700.420 Why?
Oxazolidinones12013980.410 Why?
Cycloserine120131180.410 Why?
Motivation1202220200.410 Why?
Negotiating120141520.400 Why?
Information Dissemination1202011430.390 Why?
Fluoroquinolones120143090.390 Why?
Investments120131490.390 Why?
Isoxazoles120132330.380 Why?
United States Department of Veterans Affairs120169370.380 Why?
Drug Labeling320202500.370 Why?
Drug Resistance, Bacterial2201610630.370 Why?
Cardiovascular Agents120178490.360 Why?
Politics220168220.360 Why?
Treatment Failure1201626610.350 Why?
Escherichia coli Infections120145240.340 Why?
Reimbursement, Incentive120155410.330 Why?
Drug Utilization1201511890.330 Why?
Drug Resistance, Multiple, Bacterial120145910.330 Why?
Contact Tracing120112750.320 Why?
Migraine Disorders1202217130.320 Why?
Retinal Diseases120157100.310 Why?
Ophthalmology120155600.310 Why?
Patient Selection1202042600.300 Why?
National Health Programs120114420.300 Why?
Marketing220222240.300 Why?
Prostheses and Implants1201512770.300 Why?
Molecular Targeted Therapy4202428300.300 Why?
Switzerland320233230.290 Why?
Urinary Tract Infections120148040.290 Why?
Vaccines120168430.280 Why?
Guidelines as Topic1201413970.280 Why?
Child142023809170.280 Why?
Bacterial Infections1201513970.270 Why?
Anti-Infective Agents120149830.270 Why?
Antitubercular Agents1201413970.260 Why?
Outpatients1201416000.250 Why?
Communicable Diseases120148730.250 Why?
Software1201944800.250 Why?
Canada2202221300.240 Why?
Opioid-Related Disorders1201921880.230 Why?
Therapies, Investigational220161110.230 Why?
Pain1201950990.230 Why?
Hypoglycemic Agents1201731090.230 Why?
Drugs, Generic220224550.230 Why?
Health Services Accessibility4201855200.220 Why?
Analgesics, Opioid1201938370.210 Why?
Ambulatory Care1201427830.210 Why?
Coronavirus Infections1202031150.210 Why?
Pneumonia, Viral1202032380.200 Why?
Government Agencies220191610.200 Why?
Escherichia coli1201442130.190 Why?
Cohort Studies62023417530.190 Why?
Cardiovascular Diseases22017156620.190 Why?
Patient-Centered Care2202314440.190 Why?
Quality of Life32020134900.190 Why?
Medical Oncology3202423460.170 Why?
Central Nervous System Diseases220155200.170 Why?
Television120234100.170 Why?
Prescriptions120223880.170 Why?
Tuberculosis1201120290.160 Why?
Biological Factors120191560.150 Why?
Patents as Topic120191110.150 Why?
Medicare2202168090.150 Why?
Databases, Factual4201880800.150 Why?
Japan1202214180.150 Why?
Retrospective Studies72023817600.140 Why?
Tropical Medicine12017520.140 Why?
Early Termination of Clinical Trials12016700.140 Why?
Clinical Trials, Phase I as Topic220173300.130 Why?
Cost-Benefit Analysis3202155360.130 Why?
Practice Guidelines as Topic3202474540.130 Why?
United States Government Agencies12015260.130 Why?
Time Factors52019402200.130 Why?
Conjunctivitis, Bacterial12015220.120 Why?
Neoplasm Invasiveness1202336200.120 Why?
Central Nervous System Agents12015730.120 Why?
New York120178820.120 Why?
Public Policy120195520.120 Why?
Encyclopedias as Topic12014190.120 Why?
Area Under Curve1201816430.120 Why?
Compassionate Use Trials12014500.110 Why?
Capital Financing12014580.110 Why?
Small Molecule Libraries120197420.110 Why?
Lenses, Intraocular120151410.110 Why?
Equipment Safety120142500.110 Why?
Diabetes Mellitus, Type 212017122520.100 Why?
Cross-Sectional Studies52024263790.100 Why?
Public Opinion120164860.100 Why?
Antibiotics, Antitubercular120131000.100 Why?
California1201614380.100 Why?
Infant32020365350.100 Why?
Statistics, Nonparametric2201828620.100 Why?
Age Factors22020184150.100 Why?
Safety1201611590.100 Why?
Child, Preschool32020426690.100 Why?
Clinical Trials, Phase II as Topic120146400.090 Why?
Randomized Controlled Trials as Topic32019103970.090 Why?
Diffusion of Innovation120167240.090 Why?
Adolescent52023891690.090 Why?
Models, Economic120137190.080 Why?
Germany220228830.080 Why?
Biological Products120189470.080 Why?
Regression Analysis1201863400.080 Why?
Disease-Free Survival1201868470.080 Why?
Insurance Coverage1201919460.070 Why?
Needs Assessment1201411410.070 Why?
Macular Degeneration1201510150.070 Why?
Immunotherapy1202347540.070 Why?
Infant, Newborn22019264210.070 Why?
Microbial Sensitivity Tests1201419670.070 Why?
Policy220215130.070 Why?
Periodicals as Topic1201614650.060 Why?
Aged420221715020.060 Why?
Quality Improvement1202038570.060 Why?
Neoplasm Recurrence, Local1202394190.060 Why?
Drug Prescriptions1201416680.060 Why?
Proportional Hazards Models12019125430.060 Why?
Decision Making2201539530.050 Why?
Inpatients1201525660.050 Why?
Internet1201431100.050 Why?
Treatment Outcome32019653790.050 Why?
Pandemics1202087470.040 Why?
Systems Analysis120201680.040 Why?
Developing Countries1201129100.040 Why?
France120204970.040 Why?
England120205330.040 Why?
Neglected Diseases12018670.040 Why?
Administration, Intravesical12017880.040 Why?
Follow-Up Studies12019393540.030 Why?
Computer Graphics120193440.030 Why?
Endpoint Determination120195920.030 Why?
Pharmacology, Clinical12015230.030 Why?
Male520193647310.030 Why?
Female520193971870.030 Why?
Ophthalmic Solutions120153120.030 Why?
Financing, Government120174730.030 Why?
Mental Disorders1201368730.030 Why?
Algorithms12013141640.030 Why?
Genome, Human1202444460.020 Why?
Patient Participation1201914470.020 Why?
Genomics1202459260.020 Why?
Young Adult12014600660.020 Why?
Health Care Costs1201732390.010 Why?
Middle Aged120142234870.010 Why?
Adult120142236460.010 Why?
Hwang's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (215)
Explore
_
Co-Authors (24)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.